EAY191 Molecular Analysis for Combination Therapy Choice (ComboMATCH)
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
The ComboMATCH precision medicine trial will include multiple components: this non-treatment ComboMATCH Registration Trial, an informatics component for specimen and genomic data management, and multiple ComboMATCH Treatment Trials.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 854560
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
